ecyt_Ex10_7


		
			Exhibit 10.7
		

		
			 
		

		
			ENDOCYTE, INC.
2010 EQUITY INCENTIVE PLAN
STOCK OPTION AWARD AGREEMENT
		

		
			This Award Agreement (“Award Agreement”), dated as of ___________, 20___, is by and between Endocyte, Inc., a Delaware corporation (the “Company”), and ________ (“Optionee”).  Unless otherwise defined herein, the terms defined in the Endocyte, Inc. 2010 Equity Incentive Plan (the “Plan”), shall have the same defined meanings in this Award Agreement.
		

		
			I.            NOTICE OF GRANT
		

		
			Optionee:
		

		
			«First_Name» «Middle_Initial» «Last_Name»
		

		
			The Company has granted the Optionee an option to purchase Common Stock of the Company (the “Option,”) subject to the terms and conditions of the Plan and this Award Agreement, as follows:
		

		
			Grant Number:
		

		
			Date of Grant:
		

		
			Vesting Commencement Date:
		

		
			Exercise Price per Share:
		

		
			Number of Shares:
		

		
			Total Exercise Price: Number of shares multiplied by the exercise price per share
		

		
			Type of Option: Nonstatutory Stock Option
		

		
			Term/Expiration Date:
		

		
			 
		

		
			Vesting Schedule:
		

		
			This Option shall vest in three consecutive, equal installments on the business day before each of the first three annual stockholder meetings following the date of grant, with any fractions being rounded down to the nearest whole number and made up in the last year of vesting.
		

		
			 
		

		
			II.           AGREEMENT
		

		
			1.            Grant of Option. This Award Agreement sets forth the terms and conditions of the Option granted by the Company to purchase the number of Shares set forth in the Notice of Grant, at the exercise price per Share set forth in the Notice of Grant (the “Exercise Price”). The Option is subject to the terms and conditions of the Plan, which is incorporated into this Award Agreement by reference. 
		

		
			2.            Vesting. Unless otherwise provided in this Award Agreement or in the Plan, this Option shall become exercisable in one or more installments in accordance with the Vesting Schedule set forth in the Notice of Grant.   
		

		
			3.            Option Term; Expiration Date. This Option shall expire at 5:00 p.m. Eastern Time on the Expiration Date set forth in the Notice of Grant.   
		

		
			


		 


		

			1

		


		

			 

		





 



		

			 

		


		

			 

		





		

		
			4.            Termination of Relationship as a Service Provider. If the Optionee ceases to be a Service Provider for any reason, the vested portion of this Option, if any, shall be exercisable on or before the Expiration Date as set forth in the Notice of Grant.  Except as set forth in Section 9 hereof, the unvested portion of the Option shall automatically revert to the Plan.
		

		
			5.            Exercise of Option.
		

		
			(a)          Right to Exercise. This Option shall be exercisable during its term in accordance with the Vesting Schedule set out in the Notice of Grant and with the applicable provisions of the Plan and this Award Agreement.
		

		
			(b)          Method of Exercise. This Option shall be exercisable by delivery to the Company of a notice of exercise (the “Exercise Notice”) which shall state the election to exercise the Option,  the number of Shares with respect to which the Option is being exercised (the “Exercised Shares”), and such other representations and agreements as may be required by the Company. The Exercise Notice shall be accompanied by payment of the aggregate Exercise Price as to all Exercised Shares. This Option shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the aggregate Exercise Price.
		

		
			No Shares shall be issued pursuant to the exercise of an Option unless such issuance and such exercise complies with Applicable Laws. Assuming such compliance, for income tax purposes the Shares shall be considered transferred to the Optionee on the date on which the Option is exercised with respect to such Shares.
		

		
			(c)          Method of Payment. The Optionee may pay the aggregate Exercise Price by any of the following methods, or any combination thereof:
		

		
			(i)           cash or cashier check;
		

		
			(ii)          consideration received by the Company under a formal cashless exercise program adopted by the Company in connection with the Plan; or
		

		
			(iii)         surrender of other Shares provided that, (i) such Shares have a Fair Market Value on the date of surrender equal to the aggregate Exercise Price of the Exercised Shares and (ii) accepting such Shares will not result in any adverse accounting consequences to the Company, as determined by the Administrator in its sole discretion.
		

		
			6.            Restrictions on Exercise. This Option may not be exercised if the issuance of such Shares upon such exercise or the method of payment of consideration for such Shares would constitute a violation of any Applicable Law.
		

		
			7.            Non-Transferability of Option. This Option may not be sold, pledged, assigned, hypothecated,  transferred, or disposed of in any manner otherwise than by will or by the laws of descent or distribution and may be exercised, during the lifetime of Optionee, only by Optionee. The terms of the Plan and this Award Agreement shall be binding upon the executors, administrators, heirs, successors and assigns of the Optionee.
		

		
			8.            Term of Option. This Option may be exercised only within the term set out in the Notice of Grant, and may be exercised during such term only in accordance with the Plan and the terms of this Award Agreement.
		

		
			9.            Accelerated Vesting.  
		

		
			(a)          Change in Control. In addition to the provisions made in Section 13(d) of the Plan for accelerated vesting in certain circumstances following a Change in Control, this Option or a substitute option will become fully exercisable if a successor corporation or a Parent or Subsidiary of a successor corporation assumes or substitutes for this Option following a Change and Control and the Optionee is removed from the Board before the expiration of his or her then-current term or the Optionee is not re-elected to serve as a Director upon expiration of his or her then-current term.  The accelerated vesting provisions of this Section 9(a) will not apply if the Optionee voluntarily resigns from the Board or declines to be nominated to serve another term as Director.
		

		
			


		 


		

			2

		


		

			 

		





 



		

			 

		


		

			 

		





		

		
			(b)          Resignation upon Request. This Option will become fully exercisable upon the Optionee’s resignation as a Director if such resignation was requested by the Nominating and Corporate Governance Committee of the Board. 
		

		
			10.          Tax Consequences. THE OPTIONEE SHOULD CONSULT A TAX ADVISER BEFORE EXERCISING THIS OPTION OR DISPOSING OF THE SHARES.
		

		
			III.         OTHER TERMS
		

		
			11.          Entire Agreement; Governing Law. The Plan is incorporated herein by reference. The Plan and this Award Agreement constitute the entire agreement of the parties with respect to the subject matter hereof and supersede in their entirety all prior undertakings and agreements of the Company and Optionee with respect to the subject matter hereof, and may not be modified adversely to the Optionee’s interest except by means of a writing signed by the Company and Optionee. This Award Agreement is governed by the internal substantive laws but not the choice of law rules of Indiana.
		

		
			12.          Notices. All notices and other communications required or permitted under this Award Agreement shall be written and delivered personally or sent by registered or certified first-class mail, postage prepaid and return receipt required, addressed as follows: if to the Company, to the Company's executive offices in West Lafayette, Indiana, and if to the Optionee or his or her successor, to the residence address last furnished by the Optionee to the Company.  Notwithstanding the foregoing, the Company may authorize notice by any other means it deems desirable or efficient at a given time, such as notice by facsimile or electronic mail (e-mail). Optionee agrees to notify the Company upon any change in the Optionee’s residence address.
		

		
			13.          No Guarantee of Continued Service. OPTIONEE ACKNOWLEDGES AND AGREES THAT, EXCEPT AS OTHERWISE PROVIDED IN THIS AWARD AGREEMENT OR IN THE PLAN, THE VESTING OF SHARES IS EARNED ONLY BY CONTINUING AS A SERVICE PROVIDER AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS OPTION OR ACQUIRING SHARES HEREUNDER). OPTIONEE FURTHER ACKNOWLEDGES AND AGREES THAT THIS AWARD AGREEMENT, THE TRANSACTIONS CONTEMPLATED HEREUNDER AND THE VESTING SCHEDULE SET FORTH HEREIN DO NOT CONSTITUTE AN EXPRESS OR IMPLIED PROMISE OF CONTINUED ENGAGEMENT AS A SERVICE PROVIDER FOR THE VESTING PERIOD, FOR ANY PERIOD, OR AT ALL, AND SHALL NOT INTERFERE IN ANY WAY WITH OPTIONEE’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE OPTIONEE’S RELATIONSHIP AS A SERVICE PROVIDER AT ANY TIME, WITH OR WITHOUT CAUSE.
		

		
			14.          Plan Controlling.  Subject to Section 18(c) of the Plan, in the event of a conflict between the terms and conditions of the Plan and this Award Agreement, the terms and conditions of the Plan shall prevail.  Optionee acknowledges receipt of a copy of the Plan and has reviewed the Plan and this Award Agreement in their entirety, has had an opportunity to obtain the advice of counsel and fully understands all provisions of the Award Agreement and Plan. All decisions or interpretations of the Administrator upon any questions arising under the Plan or this Award Agreement are binding, conclusive and final.
		

		
			 
		

		
			15. Acceptance and Agreement.  If Optionee does not want to accept this Option, Optionee must notify [______________] within sixty (60) days after the Date of Grant.  If Optionee does not make such a notification, Optionee will have accepted this Option and agreed to the terms and conditions set forth in this Award Agreement and in the Plan.
		

		
			 
		

		
			 
		

			
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						ENDOCYTE, INC.

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						By: 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						Name: 

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				
	
					
						 

					
					
						 

					
					
						 

					
					
						Title:

					
					
						 

					
					
						 

					
					
						 

					
					
						 

				



		
			 
		


		 


		

			3